PUBLIC-SEQUENCE RECOMBINANT ANTIBODY EXPRESSION & FLUORESCENT LABELING

Public-sequence Recombinant Antibody Expression & Fluorescent Labeling

Start with a customer sequence or a traceable paper, patent or public database record, then move through sequence review, recombinant expression, purification, fluorescent labeling and fit-for-purpose flow assessment.

01 Three starting pointsComplete sequencePaper / patent / database sourceAntibody name or research target onlyResearch use · stage-gated confirmation
START WHERE YOU ARE

You do not need every detail before starting

Submit what you have. We first identify missing information and readiness for the next stage before recommending construct design, expression or labeling.

01 · SEQUENCE READY

Complete VH / VL available

Review sequence completeness, chain pairing and intended molecular format to prepare the inputs for expression assessment.

Best for: customer-owned sequences, nucleic-acid files or plasmids
02 · SOURCE READY

Paper or patent only

Use the supplied DOI, publication number or database link to organize candidate sequences and their relationship to public examples.

Best for: rebuilding a research antibody from public sources
03 · TARGET ONLY

Name or target only

Search traceable public sources and prepare a candidate list. Search results do not imply expression feasibility or freedom to operate.

Best for: early research-planning stages
SERVICE PACKAGES

Four services for four decision points

Each stage can end with its own record. Progression is recommended only when the preceding information supports the next investment.

01SEQUENCE CHECK

Sequence check

Organize a public source or customer sequence into a record suitable for technical assessment.

  • Source and version record
  • VH / VL, CDR and chain-pairing review
  • Information gaps and risk list
Deliverable: sequence-review record
02EXPRESS

Recombinant expression

Move from a confirmed sequence and molecular format into small-scale research-grade expression and purification.

  • Construct and expression-route assessment
  • Small-scale expression and purification
  • Agreed basic quality results
Deliverable: unlabeled research-grade material
03EXPRESS + LABEL

Express + label

Connect expression and purification with StellaCyte dye, conjugation and purification capabilities.

  • Dye and reaction-route recommendation
  • Fluorescent conjugation and free-dye removal
  • Agreed labeling-results summary
Deliverable: fluorescently labeled research-grade material
04FLOW-READY

Flow application assessment

When suitable cells, antigen and controls are available, continue with a cell-binding signal assessment.

  • Application conditions and control plan
  • Fit-for-purpose flow binding experiment
  • Results record and next-step recommendation
Deliverable: agreed material and application record
PROJECT STATUS

A shared status language for every project

These terms describe project progress after initiation; they are not live customer data. Each status clarifies the current conclusion, missing information and next decision point.

  1. 01
    RECEIVED

    Request received

    Awaiting information-completeness review

  2. 02
    SOURCE REVIEW

    Source review

    Checking the public source, sequence scope and chain pairing

  3. 03
    FEASIBILITY

    Technical assessment

    Assessing molecular format, expression and labeling routes

  4. 04
    TO CONFIRM

    Plan to confirm

    Confirming scope, acceptance criteria, deliverables and boundaries

  5. 05
    IN LAB

    In the lab

    Executing expression, purification or labeling under the confirmed plan

  6. 06
    QC REVIEW

    Quality review

    Compiling agreed test results and project records

  7. 07
    DELIVERED

    Delivered

    Delivering material and agreed records with next-step recommendations

EXAMPLE PROJECT PATHS

Three example project paths

These examples show how services may be combined. They are not customer case studies, completed projects or performance claims.

EXAMPLE PATH A · PUBLIC SOURCE

Start with a patent publication

Publication and research goal → example and sequence review → candidate VH/VL record → expression-feasibility decision.

Suggested start: Sequence Check
EXAMPLE PATH B · READY SEQUENCE

From a VH / VL pair to a labeled antibody

Customer sequence → molecular-format confirmation → small-scale expression and purification → dye selection → conjugation and basic assessment.

Suggested start: Express + Label
EXAMPLE PATH C · FLOW APPLICATION

Build a custom flow-cytometry configuration

Target cells and instrument channels → antibody expression → fluorescent labeling → control confirmation → fit-for-purpose binding assessment.

Suggested start: Flow-Ready
PROJECT INPUT

Recommended inputs for assessment

Research subject
Target, antibody name or research molecule to reproduce
Available source
Patent publication, paper DOI, database link, sequence file or plasmid information
Target format
Intended species, Ig subclass, Fc, full-length antibody or fragment format
Research application
Flow cytometry, binding analysis, imaging, internalization or another research context
Project conditions
Requested scale, target dye, cell or sample conditions and time window
START WITH WHAT YOU HAVE

Submit a name, source link or sequence pair

The form collects molecular format, intended application, labeling needs and project stage so the first response can begin a focused assessment.

Start project assessment
START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Public-sequence Recombinant Antibody Expression & Fluorescent Labeling | StellaCyte Bioscience